Skip to main content
JMEE logo
JMEE
(NYSEARCA)
JPMorgan Small & Mid Cap Enhanced Equity ETF
$67.77-- (--)
Loading... - Market loading

JMEE ETF: JPMorgan Small & Mid Cap Enhanced Equity ETF - Price, Holdings & Analysis

JPMorgan Small & Mid Cap Enhanced Equity ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$66.01 - $67.90
52-Week High$71.10
52-Week Low$48.18
Open$66.19
Volume250.74K
Average Volume (3M)250.74K
Assets (AUM)2.27B
Expense Ratio0.24%
Total Holdings657
Inception DateMay 5, 2022
1 Day Change0.72%
1 Month Change-4.66%
6 Month Change5.42%
YTD Change3.08%
1 Year Change17.92%
52-Week Change19.58%
50-Day MA$68.30
200-Day MA$64.27
RSI50.35
Stochastic %K80.23
Stochastic %D55.25
Annual Dividend$0.73
Dividend Yield1.08%
Last Dividend Ex-DateDec 18, 2026
Dividend Growth YoY26.09%
Years Dividend Growth1

Frequently Asked Questions About JPMorgan Small & Mid Cap Enhanced Equity ETF

What is the current price of JMEE?

The latest JMEE price is $67.49. The 52-week range is $48.18–$71.10. JMEE has returned 19.6% over the past 52 weeks.

What is the expense ratio for JMEE?

JMEE's annual expense ratio is 0.24%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does JMEE pay dividends?

Yes, JMEE pays a 1.08% dividend yield. The last ex-dividend date was 2026-12-18. View full dividend history in the Dividends section.

What are the top holdings of JMEE?

JMEE's largest holdings are JPMorgan Prime Money Market Fund (3.6%), United Therapeutics Corporation (0.8%), Lumentum Holdings Inc (0.8%) (combined weight: 5.2%). The fund holds 657 total positions. View the complete portfolio breakdown in the Holdings section.

How does JMEE compare to similar ETFs?

Compare JMEE (0.24% expense ratio, $2.27B AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.